Printer Friendly

HERB RYAN ELECTED A CORPORATE OFFICER AND CORPORATE CONTROLLER OF PFIZER INC; CHANGES IN FINANCE DIVISIONS ANNOUNCED

 NEW YORK, Dec. 21 /PRNewswire/ -- Pfizer Inc (NYSE: PFE) announced today that it has made organizational changes in its finance divisions to become effective January 1.
 Henry McKinnell, executive vice president of Pfizer Inc, has announced that Herb Ryan, assistant controller, Corporate Accounting, has been elected a corporate officer by the Pfizer board and will become corporate controller, reporting to David Shedlarz, vice president, Finance.
 Other changes include:
 -- John Mesloh, corporate controller, and vice president, Pfizer Inc, will become vice president, Corporate Purchasing, and vice president, Pfizer Inc, replacing Jack Stoddard who is retiring as vice president, Corporate Purchasing.
 -- Claude Christiano, vice president, Operations Planning and Analysis, will become vice president, Corporate Accounting-Processes and Systems. In his new role, Mr. Christiano will lead Corporate Finance in the redevelopment of the company's major corporate accounting processes and systems.
 -- Richard Hoddeson, currently director, Special Projects, Finance, will become vice president, Operations Planning and Analysis.
 Pfizer Inc is a research-based, diversified health care company with global operations. The company reported sales of approximately $6.95 billion for 1991.
 -0- 12/21/92
 /CONTACT: Tony Biesada, 212-573-2055, or Rick Honey, 212-573-2051, both of Pfizer Inc/
 (PFE)


CO: Pfizer Inc ST: New York IN: MTC SU: PER

TS -- NY057 -- 0124 12/21/92 12:26 PST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Dec 21, 1992
Words:211
Previous Article:R.R. DONNELLEY REALIGNS GROUP MANAGEMENT
Next Article:OAK HILL SPORTSWEAR ANNOUNCES EXECUTIVE CHANGES
Topics:


Related Articles
PFIZER NAMES BESSEY HEAD OF U.S. PHARMACEUTICALS; MCKINNELL BECOMES PRESIDENT OF HOSPITAL PRODUCTS
PFIZER ANNOUNCES EXECUTIVE APPOINTMENTS.
DONALD F. FARLEY ELECTED PFIZER CORPORATE OFFICER
CYTOMED PROMOTES MICHAEL E. FITZGERALD TO VICE PRESIDENT, CHIEF FINANCIAL OFFICER
PFIZER APPOINTS KAREN L. KATEN EXECUTIVE VICE PRESIDENT OF U.S. PHARMACEUTICALS GROUP
GARDNER NAMED V.P. FOR INVESTOR RELATIONS, PFIZER INC
PFIZER BOARD ELECTS TWO CORPORATE OFFICERS
NEW CHIEF FINANCIAL OFFICER APPOINTED FOR THE ETHICAL GROUP OF ETHICAL HOLDINGS PLC
DAVID SHEDLARZ ELECTED CFO OF PFIZER INC
EDWARD C. BESSEY TO RETIRE AS VICE CHAIRMAN OF PFIZER AND PRESIDENT OF ITS U.S. PHARMACEUTICALS GROUP

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters